BOULDER, Colo., Nov. 3, 2025 /PRNewswire/ -- Enliven Therapeutics, Inc. (ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, ...
Show More All authors: Washington University School of Medicine, St Louis, MO. A currently 74-year-old white woman with hypertension, hypothyroidism, and diabetes mellitus type 2 presented initially ...
Medications for CML directly destroy cancer cells or help the body’s immune system attack cancer cells to prevent them from growing. Medications may not cure CML, so people may need to continue taking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback